Req. No. 1436 Page 1 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
STATE OF OKLAHOMA
1st Session of the 59th Legislature (2023)
SENATE BILL 228 By: Standridge
AS INTRODUCED
An Act relating to the practice of pharma cy; amending
59 O.S. 2021, Section 353.30 , which relates to
agreements; modifying term; authorizing pharmacist to
enter into collaborative practice agreements;
directing promulgation of ru les; defining term; and
providing an effective date .
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
SECTION 1. AMENDATORY 59 O.S. 2021, Section 353.30, is
amended to read as follows:
Section 353.30. A. The use of collaborative practice
agreements in the practice of pharmacy shall be acceptable within
the rules promulgated by the State Board of Pharmacy an d in
consultation with the State Board of Medical Licensure and
Supervision and the State Board of Osteopathic Examiners . A
pharmacist may enter into a collaborative practice agreement with
one or more practitioners licensed in this state .
B. The Board shall develop and prepare permanent rules relating
to collaborative practice agreements including, but not limited to,
training requirements and administration of immunizations and
Req. No. 1436 Page 2 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
therapeutic injections in consultatio n within the State Board of
Medical Licensure and S upervision and the State Board of Osteopathic
Examiners.
C. A pharmacist who has completed a requisite course of
training as approved by the Board in consultation with the State
Board of Medical Licensure and Supervision and the State Board of
Osteopathic Examiners may administer therapeutic injections on
orders from a licensed prescriber, and may administer immunizations
that have been approved or authorized by the Food an d Drug
Administration without a p atient-specific prescription, standing
order or similar arrangement.
D. As used in this section, “collaborative practice agre ement”
means a formal agreement in which a licensed practitioner makes a
diagnosis, supervises patient care, and refers patients t o a
pharmacist under a protocol that allows the pha rmacist to perform
specific patient care functio ns including, but not limited to,
administration of immunizations and therapeutic injections .
SECTION 2. This act shall become effective Nov ember 1, 2023.
59-1-1436 DC 1/9/2023 6:14:14 PM